Weil Advises inVentiv Health in its $4.6B Merger with INC Research

Print Print

Weil is advising inVentiv Health, Inc., and selling shareholders Thomas H. Lee Partners and Advent International, in its definitive agreement with INC Research Holdings, Inc. under which the two companies will combine in an all-stock merger of equals transaction valued at approximately $4.6 billion. The merger will create the second largest biopharmaceutical outsourcing provider focused on creating value for customers, patients, physicians, payers and employees and have an enterprise value of approximately $7.4 billion. The combined company will have more than 22,000 employees spanning more than 60 countries, and will serve customers in more than 110 countries. Advent International and Thomas H. Lee Partners will remain investors in the combined company upon closing of the merger. The transaction is expected to be completed in the second half of 2017, subject to customary closing conditions.

The Weil team advising inVentiv is led by Corporate Chairman Michael Aiello and includes Mergers & Acquisitions partner Sachin Kohli and associates Adam Templeton, Kimberly Thibault, Kelsey Pfleger and Daniel Waxman; Banking & Finance partner Courtney Marcus; Capital Markets partner Heather Emmel; Technology & IP Transactions Head Michael Epstein; Tax partner Mark Hoenig; Executive Compensation & Benefits partner Amy Rubin; Real Estate partner David Herman; Antitrust partner John Scribner; Employment Litigation partner Gary Friedman; Securities Litigation partner Robert Carangelo; Environmental counsel John O’Loughlin; Banking & Finance associates Benton Lewis and Brendan Conley; Capital Markets associate Aman Singh; Technology & IP Transactions associates Lauren Springer and Alexa Rozell (Not Yet Admitted in New York); Tax associate Scott Fryman; Executive Compensation & Benefits associates Amanda Rosenblum and John Kleinjan (Not Yet Admitted in New York); Real Estate associate Caitlin Steiger; Antitrust associate Jonathan Cheng; Employment Litigation associate Marissa Flood (Not Yet Admitted in New York); and Securities Litigation associates Raquel Kellert and Jonnah Hollander.